查找临床试验
已按「骨髓纤维化」检索，对应国际通用词 myelofibrosis
共找到 87 项正在招募的试验（在欧美日韩等发达国家设有中心）
数据更新于 23:03，每 5 分钟自动同步A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
United States
年龄 18 Years – 不限
Incyte Corporation
High Dose Ruxolitinib and Allogeneic Stem Cell Transplantation in Myelofibrosis Patients With Splenomegaly
United States
年龄 18 Years – 75 Years
M.D. Anderson Cancer Center
Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or Secondary Myelofibrosis
United States
年龄 18 Years – 70 Years
Fred Hutchinson Cancer Center
Pacritinib For Bone Marrow Fibrosis In Patients With Myelofibrosis Who Have Thrombocytopenia
Spain
年龄 18 Years – 不限
Grupo Español de Enfermedades Mieloproliferativas Crónicas PH Negativas
A Telehealth Advance Care Planning Intervention
United States
年龄 60 Years – 不限
University of Rochester
A Study to Evaluate DMR-001 in Participants With CALR-mutant Myeloproliferative Neoplasms
United States、Australia
年龄 18 Years – 不限
Damora Therapeutics
MPNdpoint. Single-center, Retrospective, Prospective Study of the Outcome of Patients With Philadelphia-negative Chronic Myeloproliferative Neoplasms
Italy
年龄 16 Years – 不限
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
United States
年龄 18 Years – 120 Years
UNC Lineberger Comprehensive Cancer Center
CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
United States
年龄 18 Years – 75 Years
City of Hope Medical Center
Functional and Phenotypic Characterization of Monocytes in Myeloproliferative Syndromes
France
年龄 18 Years – 不限
University Hospital, Angers
Ruxolitinib in Primary Myelofibrosis and Secondary to Essential Thrombocythemia or Polycythemia Vera
Italy
年龄 18 Years – 不限
IRCCS Azienda Ospedaliero-Universitaria di Bologna
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
United States、Australia、Belgium、Bulgaria、Canada 等 12 国
年龄 18 Years – 不限
Celgene